Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)

Clinical trial NCT04218851 · COMPLETED

Trial details

NCT number: NCT04218851
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Aspergillosis

Start date: 2020-07-02
Primary completion: 2023-12-18
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.